President Trump promised to lower the cost of Ozempic to $150. Mark Cuban says he's working from the same playbook as Cost Plus, giving consumers transparent prices.

A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President Donald Trump was discussing efforts to lower the cost of GLP-1 medications.

Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in its key drugs Ozempic and Wegovy, in a deal that some analysts said sounded less onerous than feared.

Novo Nordisk lowered its guidance in part due to disappointing demand for Ozempic. Key Takeaways. Novo Nordisk cut its outlook as it sees

The ultimate defense in our industry is in innovation,” Karsten Munk Knudsen told Fortune in an exclusive interview.

Novo Nordisk stock slid Wednesday after the Danish drugmaker’s third-quarter results missed estimates, and it trimmed its full-year guidance. Notably, sales growth for its blockbuster obesity drug Wegovy keeps slowing in the race against Eli Lilly.